Cell & Gene Therapy - Event guide: The 7th Gene Therapy Analytical Development Europe
View as a Web Page
News Medical
 
  Cell & Gene Therapy Cell & Gene Therapy logo  
  The latest stem cells news from News Medical  
 

Guide for Sourcing CGT Cellular Starting MaterialsGuide for Sourcing CGT Cellular Starting Materials

Read about critical considerations when sourcing raw materials that impact can impact your therapy, how to avoid common delays that stall development and regulatory approval, the essential components of a GMP framework, strategies to find a trusted vendor including an evaluation checklist, and more.

Download the eBook
 
 
    Event guide: The 7th Gene Therapy Analytical Development EuropeEvent guide: The 7th Gene Therapy Analytical Development Europe
 
As gene therapy regains momentum across Europe, analytical strategy has become a critical focus for programs progressing into late-stage development and regulatory review.
 
Download Your Guide
 
 
   Life Science and Biotech Trends for 2026Life Science and Biotech Trends for 2026
 
Advancements in AI, multi-omics, and genome editing are transforming life sciences and biotechnology, addressing new regulatory and data challenges by 2026.
 
 What Is the Difference Between siRNA and shRNA Knockdown Methods?
 
What Is the Difference Between siRNA and shRNA Knockdown Methods?Explore RNA interference methods, comparing siRNA and shRNA for gene knockdown, their mechanisms, advantages, and implications for molecular biology research.
 
 
 Gene therapy targeting connexin 43 shows promise across inherited heart diseases
 
Gene therapy targeting connexin 43 shows promise across inherited heart diseasesUniversity of California San Diego-led team has discovered that restoring a key cardiac protein called connexin‑43 in a mouse model can dramatically improve heart function and extend survival in several inherited forms of arrhythmogenic cardiomyopathy (ACM)
 
 
 First topical CRISPR gene therapy corrects disease-causing mutations in human skin
 
First topical CRISPR gene therapy corrects disease-causing mutations in human skinGene-editing tools like CRISPR have unlocked new treatments for previously uncurable diseases. Now, researchers at the University of British Columbia are extending those possibilities to the skin for the first time.
 
 
 ERC Proof of Concept grant supports promising CRISPR-based cancer treatment research
 
ERC Proof of Concept grant supports promising CRISPR-based cancer treatment researchMicrobiologist John van der Oost of Wageningen University & Research (WUR) has received an ERC Proof of Concept grant to further develop a promising CRISPR-based approach to cancer treatment. With funding of €150,000, he and researcher Christian Südfeld will spend the next eighteen months working on a method to kill cancer cells from within, while sparing healthy cells as much as possible.
 
 
 New workflow boosts nuclear delivery for safer gene therapy
 
New workflow boosts nuclear delivery for safer gene therapyGene therapy holds the promise of preventing and curing disease by manipulating gene expression within a patient's cells. However, to be effective, the new gene must make it into a cell's nucleus.
 
 
 CRISPR gene-drive technology reverses antibiotic resistance in bacteria
 
CRISPR gene-drive technology reverses antibiotic resistance in bacteriaAntibiotic resistance (AR) has steadily accelerated in recent years to become a global health crisis. As deadly bacteria evolve new ways to elude drug treatments for a variety of illnesses, a growing number of "superbugs" have emerged, ramping up estimates of more than 10 million worldwide deaths per year by 2050.
 
 
 AI model accelerates antibody production and clone selection
 
AI model accelerates antibody production and clone selectionAs instigators of immunity, monoclonal antibodies are marvels of modern medicine, lab-made proteins that can treat cancers, autoimmune diseases, and many other conditions.
 
 
 Global trends shape progress in cell and gene therapies
 
Global trends shape progress in cell and gene therapiesCell and gene therapies, or CGT, have come a long way since they were first introduced. In the last few decades, both cell therapy -- the transplantation of living cells -- and gene therapy -- the use of genetic material to modify cell functions -- have been increasingly incorporated into clinical practice.
 
 
 Researchers find new way to halt leukemia stem cell growth
 
Researchers find new way to halt leukemia stem cell growthIn a new study published in Nature Communications, a research team at the University of Oslo have examined how cancer cells develop in the bone marrow and whether it might be possible to stop them.
 
 
 Expanding CRISPR to Tackle Incurable Skin Diseases
 
Expanding CRISPR to Tackle Incurable Skin DiseasesGene-editing techniques such as CRISPR have enabled new treatments for previously incurable diseases. Researchers at the University of British Columbia are now expanding those capabilities to include the skin for the first time.
 
 

How would you rate today's newsletter?

 
             
 
 
Google News Icon Stay updated with the latest in health and medical news! Follow News‑Medical.net on Google News for real‑time updates. Click here to follow us now.
 
Facebook X Instagram LinkedIn Vimeo
Why did you receive this email?
You are receiving this email because you subscribed to updates from AZoNetwork UK Ltd. on one of our websites and requested to be notified of additional information.

Unsubscribe or Update Notification Preferences

Contact | About | Privacy Policy

- - - - - -

Registered Address:
AZoNetwork UK Ltd., NEO, 9 Charlotte St, Manchester, M1 4ET, UK

Manchester | Sydney | Boston

Copyright © 2000-2026